NCT02576600

Brief Summary

The aim of this prospective randomized study was to evaluate the impact of peroperative pupillometry monitoring on per and post-operative opioid consumption in major gynecological surgery. All patients were anesthetized with TCI of propofol and remifentanil. In the intervention group, peroperative remifentanil target was guided by pupillometry. In the other group, remifentanil was administered according to standard practice.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
Completed

Started Oct 2010

Longer than P75 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

October 13, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 15, 2015

Completed
Last Updated

October 19, 2015

Status Verified

October 1, 2015

Enrollment Period

2.2 years

First QC Date

October 13, 2015

Last Update Submit

October 16, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • peroperative remifentanil consumption in µg/kg/min

    duration of surgery

Secondary Outcomes (2)

  • post-operative morphine requirements in mg/kg

    24 hours

  • peroperative propofol consumption in mg/kg/h

    duration of surgery

Study Arms (2)

PUPILLO

EXPERIMENTAL

Videopupillometer Algiscan peroperative remifentanil target concentration adapted every five minutes to pupillary diameter in patients under propofol and remifentanil TCI

Device: Videopupillometer AlgiscanDrug: PropofolDrug: Remifentanil

STANDARD

SHAM COMPARATOR

peroperative remifentanil target concentration as standard practice in patients under propofol and remifentanil TCI

Other: Standard practiceDrug: PropofolDrug: Remifentanil

Interventions

pupillary diameter measurement every five minutes per-operatively

PUPILLO

remifentanil administration left to the discretion of the anesthesiologist in charge according to standard practice

STANDARD

TCI

PUPILLOSTANDARD

TCI

PUPILLOSTANDARD

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • ASA I-II
  • Elective gynecological surgery
  • No ophtalmologic or neurologic disease
  • No chronic analgesic medication
  • Expected length of surgery 60 minutes minimum

You may not qualify if:

  • ophtalmologic or neurologic disease
  • chronic analgesic medication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Departement d'anesthesie Hopital Armand Trousseau

Paris, 75012, France

Location

MeSH Terms

Conditions

Pain

Interventions

PropofolRemifentanil

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsPropionatesAcids, AcyclicCarboxylic AcidsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Isabelle Constant, MD-PHD

    Hôpital Armand Trousseau

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor Isabelle Constant

Study Record Dates

First Submitted

October 13, 2015

First Posted

October 15, 2015

Study Start

October 1, 2010

Primary Completion

December 1, 2012

Study Completion

April 1, 2013

Last Updated

October 19, 2015

Record last verified: 2015-10

Locations